Literature DB >> 19752767

Reconstitution of the mast cell population in W/Wv mice.

Jörg Ebmeyer1, Umay Ebmeyer, Kwang Pak, Holger Sudhoff, David Broide, Allen F Ryan, Stephen Wasserman.   

Abstract

HYPOTHESIS: Intravenous injection of cultured mast cells (MCs) can reconstitute the MC population in MC-deficient mice. We hypothesize that injected culture-derived MCs do not repopulate all tissues equally.
BACKGROUND: Mast cells are central elements not only in anaphylaxis and allergy but also in immune reactions to bacteria and other pathogens. Their broad involvement in innate immunity requires extensive research in the future. Studies of MC function often use MC-deficient mice to compare with wild-type animals. A very elegant method to prove that the observed changes are due to the lack of MCs is to compare results in wild-type mice, MC-deficient mice, and MC-deficient mice that have been reconstituted with cultured MCs. Reconstitution of the MC population can be achieved by intravenous injection of MCs into MC-deficient mice. Whether the injected MCs repopulate the desired tissues has to be proven before this model is used. Also, the time frame of the reconstitution has to be demonstrated.
METHODS: Mast cell-deficient mice were injected with bone marrow-derived cultured MCs, and the mucosa of middle ear (MEs), nose, and tracheobronchial system was analyzed for MCs 4, 6, 8, 10, and 20 weeks after injection.
RESULTS: Reconstitution of the ME mucosa was complete and persistent for more than 20 weeks. Reconstitution failed in nasal mucosa. In bronchial mucosa, reconstitution was incomplete and transient.
CONCLUSION: This model can be used to investigate effects of MCs in various immune reactions in the ME. Studies should use the time frame 6 to 8 weeks after reconstitution of the MC population. However, the model has limitations for investigations in the respiratory tract.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19752767      PMCID: PMC2796298          DOI: 10.1097/MAO.0b013e3181b4e3e3

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  12 in total

1.  Middle ear mucosa in rats and humans.

Authors:  N Albiin; S Hellström; L E Stenfors; A Cerne
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  1986 Sep-Oct

Review 2.  Mast cells in infection and immunity.

Authors:  S N Abraham; R Malaviya
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

3.  The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48.

Authors:  R Malaviya; Z Gao; K Thankavel; P A van der Merwe; S N Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

4.  Clonal nature of mast-cell clusters formed in W/Wv mice after bone marrow transplantation.

Authors:  Y Kitamura; H Matsuda; K Hatanaka
Journal:  Nature       Date:  1979-09-13       Impact factor: 49.962

5.  Role of mast cells in otitis media.

Authors:  Jörg Ebmeyer; Masayuki Furukawa; Kwang Pak; Umay Ebmeyer; Holger Sudhoff; David Broide; Allen F Ryan; Stephen Wasserman
Journal:  J Allergy Clin Immunol       Date:  2005-09-28       Impact factor: 10.793

Review 6.  Mast cells as sentinels of innate immunity.

Authors:  S J Galli; M Maurer; C S Lantz
Journal:  Curr Opin Immunol       Date:  1999-02       Impact factor: 7.486

Review 7.  Analyzing mast cell development and function using mice carrying mutations at W/c-kit or Sl/MGF (SCF) loci.

Authors:  S J Galli; M Tsai; J R Gordon; E N Geissler; B K Wershil
Journal:  Ann N Y Acad Sci       Date:  1992       Impact factor: 5.691

8.  Long-term in vitro culture of murine mast cells. I. Description of a growth factor-dependent culture technique.

Authors:  G Tertian; Y P Yung; D Guy-Grand; M A Moore
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

9.  Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course.

Authors:  Melinda B Tanzola; Michaela Robbie-Ryan; Claire Anne Gutekunst; Melissa A Brown
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

10.  Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells.

Authors:  T Nakano; T Sonoda; C Hayashi; A Yamatodani; Y Kanayama; T Yamamura; H Asai; T Yonezawa; Y Kitamura; S J Galli
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Mast cells and metabolic syndrome.

Authors:  Jie Zhang; Guo-Ping Shi
Journal:  Biochim Biophys Acta       Date:  2010-12-23

Review 2.  Practical murine hematopathology: a comparative review and implications for research.

Authors:  Karyn E O'Connell; Amy M Mikkola; Aaron M Stepanek; Andyna Vernet; Christopher D Hall; Chia C Sun; Eda Yildirim; John F Staropoli; Jeannie T Lee; Diane E Brown
Journal:  Comp Med       Date:  2015-04       Impact factor: 0.982

3.  Critical role of tissue mast cells in controlling long-term glucose sensor function in vivo.

Authors:  Ulrike Klueh; Manjot Kaur; Yi Qiao; Donald L Kreutzer
Journal:  Biomaterials       Date:  2010-03-11       Impact factor: 12.479

4.  Headbobber: a combined morphogenetic and cochleosaccular mouse model to study 10qter deletions in human deafness.

Authors:  Annalisa Buniello; Rachel E Hardisty-Hughes; Johanna C Pass; Eva Bober; Richard J Smith; Karen P Steel
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

5.  Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine.

Authors:  Natt Tasaniyananda; Urai Chaisri; Anchalee Tungtrongchitr; Wanpen Chaicumpa; Nitat Sookrung
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.